MDLZ: Mondelez International Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Mondelez International Inc (MDLZ).
$79.87B Market Cap.
MDLZ Market Cap. (MRY)
MDLZ Shares Outstanding (MRY)
MDLZ Assets (MRY)
Total Assets
$68.50B
Total Liabilities
$41.54B
Total Investments
$635.00M
MDLZ Income (MRY)
Revenue
$36.44B
Net Income
$4.61B
Operating Expense
$7.91B
MDLZ Cash Flow (MRY)
CF Operations
$4.91B
CF Investing
$526.00M
CF Financing
-$5.78B
MDLZ Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $68,497,000,000 (-4.05%) | $71,391,000,000 (0.32%) | $71,161,000,000 (6.06%) | $67,092,000,000 (-1.06%) |
Assets Current | $13,242,000,000 (13.15%) | $11,703,000,000 (15.97%) | $10,091,000,000 (-2.43%) | $10,342,000,000 (3.64%) |
Assets Non-Current | $55,255,000,000 (-7.43%) | $59,688,000,000 (-2.26%) | $61,070,000,000 (7.61%) | $56,750,000,000 (-1.87%) |
Goodwill & Intangible Assets | $41,865,000,000 (-4.27%) | $43,732,000,000 (1.33%) | $43,160,000,000 (7.18%) | $40,269,000,000 (-0.27%) |
Shareholders Equity | $26,932,000,000 (-4.94%) | $28,332,000,000 (5.39%) | $26,883,000,000 (-4.90%) | $28,269,000,000 (2.51%) |
Property Plant & Equipment Net | $10,248,000,000 (-1.24%) | $10,377,000,000 (7.20%) | $9,680,000,000 (4.41%) | $9,271,000,000 (-4.07%) |
Cash & Equivalents | $1,351,000,000 (-25.36%) | $1,810,000,000 (-5.88%) | $1,923,000,000 (-45.77%) | $3,546,000,000 (-2.02%) |
Accumulated Other Comprehensive Income | -$12,471,000,000 (-13.93%) | -$10,946,000,000 (0.01%) | -$10,947,000,000 (-3.04%) | -$10,624,000,000 (0.62%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $635,000,000 (-80.41%) | $3,242,000,000 (-33.55%) | $4,879,000,000 (-7.75%) | $5,289,000,000 (-12.38%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $635,000,000 (-80.41%) | $3,242,000,000 (-33.55%) | $4,879,000,000 (-7.75%) | $5,289,000,000 (-12.38%) |
Inventory | $3,827,000,000 (5.86%) | $3,615,000,000 (6.92%) | $3,381,000,000 (24.85%) | $2,708,000,000 (2.30%) |
Trade & Non-Trade Receivables | $4,811,000,000 (6.63%) | $4,512,000,000 (15.49%) | $3,907,000,000 (22.55%) | $3,188,000,000 (7.92%) |
Trade & Non-Trade Payables | $9,433,000,000 (13.36%) | $8,321,000,000 (10.04%) | $7,562,000,000 (12.36%) | $6,730,000,000 (8.39%) |
Accumulated Retained Earnings (Deficit) | $36,476,000,000 (6.54%) | $34,236,000,000 (8.75%) | $31,481,000,000 (2.19%) | $30,806,000,000 (8.46%) |
Tax Assets | $333,000,000 (-18.38%) | $408,000,000 (-13.74%) | $473,000,000 (-12.57%) | $541,000,000 (-31.52%) |
Tax Liabilities | $3,425,000,000 (4.04%) | $3,292,000,000 (-4.22%) | $3,437,000,000 (-0.20%) | $3,444,000,000 (2.93%) |
Total Debt | $18,372,000,000 (-7.89%) | $19,945,000,000 (-14.94%) | $23,447,000,000 (17.41%) | $19,971,000,000 (-2.66%) |
Debt Current | $2,085,000,000 (-17.29%) | $2,521,000,000 (-6.00%) | $2,682,000,000 (36.70%) | $1,962,000,000 (-29.17%) |
Debt Non-Current | $16,287,000,000 (-6.53%) | $17,424,000,000 (-16.09%) | $20,765,000,000 (15.30%) | $18,009,000,000 (1.48%) |
Total Liabilities | $41,539,000,000 (-3.45%) | $43,025,000,000 (-2.75%) | $44,241,000,000 (14.11%) | $38,769,000,000 (-3.45%) |
Liabilities Current | $19,549,000,000 (2.82%) | $19,013,000,000 (13.64%) | $16,731,000,000 (19.44%) | $14,008,000,000 (-7.59%) |
Liabilities Non-Current | $21,990,000,000 (-8.42%) | $24,012,000,000 (-12.72%) | $27,510,000,000 (11.10%) | $24,761,000,000 (-0.94%) |
MDLZ Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $36,441,000,000 (1.18%) | $36,016,000,000 (14.35%) | $31,496,000,000 (9.67%) | $28,720,000,000 (8.05%) |
Cost of Revenue | $22,184,000,000 (-0.31%) | $22,252,000,000 (10.25%) | $20,184,000,000 (15.56%) | $17,466,000,000 (8.25%) |
Selling General & Administrative Expense | $7,439,000,000 (-7.04%) | $8,002,000,000 (8.37%) | $7,384,000,000 (17.90%) | $6,263,000,000 (2.71%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $7,912,000,000 (-4.24%) | $8,262,000,000 (6.22%) | $7,778,000,000 (17.83%) | $6,601,000,000 (0.12%) |
Interest Expense | $180,000,000 (-41.94%) | $310,000,000 (-26.71%) | $423,000,000 (-5.37%) | $447,000,000 (-26.48%) |
Income Tax Expense | $1,469,000,000 (-4.42%) | $1,537,000,000 (77.69%) | $865,000,000 (-27.31%) | $1,190,000,000 (-2.78%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $4,623,000,000 (-6.94%) | $4,968,000,000 (82.25%) | $2,726,000,000 (-36.81%) | $4,314,000,000 (20.87%) |
Net Income to Non-Controlling Interests | $12,000,000 (33.33%) | $9,000,000 (0.00%) | $9,000,000 (-35.71%) | $14,000,000 (0.00%) |
Net Income | $4,611,000,000 (-7.02%) | $4,959,000,000 (82.52%) | $2,717,000,000 (-36.81%) | $4,300,000,000 (20.96%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $4,611,000,000 (-7.02%) | $4,959,000,000 (82.52%) | $2,717,000,000 (-36.81%) | $4,300,000,000 (20.96%) |
Weighted Average Shares | $1,337,194,254 (-1.74%) | $1,360,895,585 (-0.35%) | $1,365,618,508 (-2.10%) | $1,394,972,132 (-2.46%) |
Weighted Average Shares Diluted | - | - | - | - |
Earning Before Interest & Taxes (EBIT) | $6,260,000,000 (-8.02%) | $6,806,000,000 (69.94%) | $4,005,000,000 (-32.54%) | $5,937,000,000 (10.21%) |
Gross Profit | $14,257,000,000 (3.58%) | $13,764,000,000 (21.68%) | $11,312,000,000 (0.52%) | $11,254,000,000 (7.74%) |
Operating Income | $6,345,000,000 (15.32%) | $5,502,000,000 (55.69%) | $3,534,000,000 (-24.05%) | $4,653,000,000 (20.76%) |
MDLZ Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $526,000,000 (-81.29%) | $2,812,000,000 (157.53%) | -$4,888,000,000 (-18700.00%) | -$26,000,000 (-105.20%) |
Net Cash Flow from Financing | -$5,780,000,000 (23.52%) | -$7,558,000,000 (-1557.46%) | -$456,000,000 (88.79%) | -$4,069,000,000 (-83.70%) |
Net Cash Flow from Operations | $4,910,000,000 (4.16%) | $4,714,000,000 (20.62%) | $3,908,000,000 (-5.63%) | $4,141,000,000 (4.47%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$484,000,000 (-656.25%) | -$64,000,000 (96.01%) | -$1,605,000,000 (-1554.64%) | -$97,000,000 (-104.18%) |
Net Cash Flow - Business Acquisitions and Disposals | $2,054,000,000 (-50.12%) | $4,118,000,000 (187.90%) | -$4,685,000,000 (-763.60%) | $706,000,000 (-47.82%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$157,000,000 (26.29%) | -$213,000,000 (-130.30%) | $703,000,000 (201.72%) | $233,000,000 (2230.00%) |
Capital Expenditure | -$1,371,000,000 (-25.43%) | -$1,093,000,000 (-20.64%) | -$906,000,000 (6.11%) | -$965,000,000 (-11.82%) |
Issuance (Repayment) of Debt Securities | -$1,226,000,000 (69.53%) | -$4,024,000,000 (-219.34%) | $3,372,000,000 (2654.55%) | -$132,000,000 (-118.28%) |
Issuance (Purchase) of Equity Shares | -$2,334,000,000 (-50.87%) | -$1,547,000,000 (23.30%) | -$2,017,000,000 (4.41%) | -$2,110,000,000 (-51.80%) |
Payment of Dividends & Other Cash Distributions | -$2,349,000,000 (-8.75%) | -$2,160,000,000 (-8.82%) | -$1,985,000,000 (-8.71%) | -$1,826,000,000 (-8.82%) |
Effect of Exchange Rate Changes on Cash | -$140,000,000 (-337.50%) | -$32,000,000 (81.07%) | -$169,000,000 (-18.18%) | -$143,000,000 (-295.89%) |
Share Based Compensation | $147,000,000 (0.68%) | $146,000,000 (21.67%) | $120,000,000 (-0.83%) | $121,000,000 (-3.97%) |
Depreciation Amortization & Accretion | $1,302,000,000 (7.16%) | $1,215,000,000 (9.76%) | $1,107,000,000 (-0.54%) | $1,113,000,000 (-0.27%) |
MDLZ Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 39.10% (2.36%) | 38.20% (6.41%) | 35.90% (-8.42%) | 39.20% (-0.25%) |
Profit Margin | 12.70% (-7.97%) | 13.80% (60.47%) | 8.60% (-42.67%) | 15.00% (11.94%) |
EBITDA Margin | 20.80% (-6.73%) | 22.30% (37.65%) | 16.20% (-33.88%) | 24.50% (0.00%) |
Return on Average Equity (ROAE) | 16.60% (-4.60%) | 17.40% (74.00%) | 10.00% (-35.90%) | 15.60% (16.42%) |
Return on Average Assets (ROAA) | 6.30% (-8.70%) | 6.90% (72.50%) | 4.00% (-37.50%) | 6.40% (18.52%) |
Return on Sales (ROS) | 17.20% (-8.99%) | 18.90% (48.82%) | 12.70% (-38.65%) | 20.70% (1.97%) |
Return on Invested Capital (ROIC) | 23.80% (2.59%) | 23.20% (81.25%) | 12.80% (-36.95%) | 20.30% (10.93%) |
Dividend Yield | 2.20% (0.00%) | 2.20% (0.00%) | 2.20% (10.00%) | 2.00% (-4.76%) |
Price to Earnings Ratio (P/E) | 17.36 (-12.74%) | 19.9 (-41.19%) | 33.83 (56.12%) | 21.67 (-8.09%) |
Price to Sales Ratio (P/S) | 2.19 (-19.91%) | 2.74 (-5.29%) | 2.89 (-10.28%) | 3.22 (2.38%) |
Price to Book Ratio (P/B) | 2.97 (-14.75%) | 3.48 (2.75%) | 3.39 (3.48%) | 3.27 (7.92%) |
Debt to Equity Ratio (D/E) | 1.54 (1.51%) | 1.52 (-7.72%) | 1.65 (20.06%) | 1.37 (-5.84%) |
Earnings Per Share (EPS) | 3.44 (-5.49%) | 3.64 (84.77%) | 1.97 (-35.62%) | 3.06 (23.39%) |
Sales Per Share (SPS) | 27.25 (2.97%) | 26.46 (14.75%) | 23.06 (12.03%) | 20.59 (10.77%) |
Free Cash Flow Per Share (FCFPS) | 2.65 (-0.53%) | 2.66 (21.06%) | 2.2 (-3.47%) | 2.28 (5.03%) |
Book Value Per Share (BVPS) | 20.14 (-3.26%) | 20.82 (5.76%) | 19.69 (-2.86%) | 20.27 (5.09%) |
Tangible Assets Book Value Per Share (TABVPS) | 19.92 (-2.01%) | 20.32 (-0.88%) | 20.5 (6.64%) | 19.23 (0.24%) |
Enterprise Value Over EBIT (EV/EBIT) | 16 (-5.88%) | 17 (-39.29%) | 28 (55.56%) | 18 (-5.26%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 13.06 (-10.77%) | 14.64 (-32.60%) | 21.72 (39.75%) | 15.54 (-0.39%) |
Asset Turnover | 0.5 (-0.40%) | 0.5 (8.89%) | 0.46 (7.21%) | 0.43 (5.91%) |
Current Ratio | 0.68 (9.90%) | 0.62 (2.16%) | 0.6 (-18.29%) | 0.74 (12.16%) |
Dividends | $1.32 (-18.52%) | $1.62 (10.20%) | $1.47 (10.53%) | $1.33 (10.83%) |
Free Cash Flow (FCF) | $3,539,000,000 (-2.26%) | $3,621,000,000 (20.62%) | $3,002,000,000 (-5.48%) | $3,176,000,000 (2.42%) |
Enterprise Value (EV) | $98,778,612,791 (-15.87%) | $117,411,667,222 (5.75%) | $111,028,473,558 (1.34%) | $109,562,602,073 (7.99%) |
Earnings Before Tax (EBT) | $6,080,000,000 (-6.40%) | $6,496,000,000 (81.35%) | $3,582,000,000 (-34.75%) | $5,490,000,000 (14.88%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $7,562,000,000 (-5.72%) | $8,021,000,000 (56.91%) | $5,112,000,000 (-27.49%) | $7,050,000,000 (8.41%) |
Invested Capital | $24,104,000,000 (-10.00%) | $26,781,000,000 (-18.34%) | $32,794,000,000 (12.15%) | $29,240,000,000 (0.24%) |
Working Capital | -$6,307,000,000 (13.72%) | -$7,310,000,000 (-10.09%) | -$6,640,000,000 (-81.12%) | -$3,666,000,000 (29.23%) |
Tangible Asset Value | $26,632,000,000 (-3.71%) | $27,659,000,000 (-1.22%) | $28,001,000,000 (4.39%) | $26,823,000,000 (-2.22%) |
Market Capitalization | $79,870,612,791 (-18.97%) | $98,569,667,222 (8.30%) | $91,018,473,558 (-1.60%) | $92,500,602,073 (10.62%) |
Average Equity | $27,739,250,000 (-2.45%) | $28,435,500,000 (4.16%) | $27,299,000,000 (-1.26%) | $27,646,250,000 (4.12%) |
Average Assets | $72,852,000,000 (1.51%) | $71,765,500,000 (5.07%) | $68,301,250,000 (2.23%) | $66,808,750,000 (2.06%) |
Invested Capital Average | $26,250,500,000 (-10.37%) | $29,287,250,000 (-6.51%) | $31,325,000,000 (6.92%) | $29,297,750,000 (-0.64%) |
Shares | 1,337,194,254 (-1.74%) | 1,360,895,585 (-0.35%) | 1,365,618,508 (-2.10%) | 1,394,972,132 (-2.46%) |
